Confidence:
The Alcon Advantage

IOL Options for Every Patient

Confidence: The Alcon Advantage

IOL Options for Every Patient

Clareon^® Vivity^® IOL

Simplifying presbyopia correction on Alcon's high-tech lens platform.^1-10

A close-up shot of a car’s left passenger side headlight illuminating the dark. A vertical line divides the headlight in two, with a starburst effect on the light on the left side of the line.

Clareon^® PanOptix^® IOL

PanOptix^® delivers a pristine⁹ high-quality visual experience from far to near, with 99% patient satisfaction and over 2.2 million implants worldwide.^11-15

An image of an arm in the foreground with a blue and white background, featuring a hand holding an intertwined gold medal with a red and blue ribbon.

AcrySof^® IQ Monofocal IOL and AcrySof^® IQ Toric IOL

The trusted IOLs that give you confidence.⁷

An image of printed research papers placed on the ground in such a way that the borders of the papers create the outline of an IOL. An iPad lies on top of the papers, displaying a title page to a study on the AcrySof IQ platform. A blue medical mask lies next to the iPad. This all appears on a grey background.

Clareon^® Monofocal IOL

Our most advanced lens design that delivers pristine visual outcomes with consistency and certainty.^8-10

A close-up image of two intraocular lenses overlaid with a blue background.

Alcon Experience Academy

For relevant training content from industry thought leaders

Visit AEA Portal

References:
1. Clareon^® Vivity^® Extended Vision IOL Directions for Use.
2. Alcon Data on File, 2018. US Patent 9968440 B2.
3. Bala C, et al. Multi-country clinical outcomes of a new nondiffractive presbyopia-correcting intraocular lens. J Cataract Refract Surg. 2021: Ahead of print. doi:10.1097/j.jcrs.0000000000000712.
4. Alcon Data on File, 2019. TDOC-0055576.
5. Alcon Data on File, 2019. TDOC-0056718.
6. Ligabue E, et al. ACRYSOF IQ VIVITY: Natural vision at a range of distances provided by a novel optical technology. Cataract & Refractive Surgery Today. April 2020.
7. Alcon Data on File. A02062-REP-043696, Optical Evaluations of Alcon Vivity^®, Symfony*, and Zeiss* AT LARA* IOLs.
8. Lawless M. Insight news. “An IOL to change the cataract surgery paradigm?” available at “https://insightnews.com.au/an-iol-to-change-the-cataract-surgery-paradigm/”. Accessed 17 Jul 2020.
9. Ahmed I, et al. The Vivity Extended Depth of Focus IOL: Our Clinical Experience. Cataract & Refractive Surgery Today. February 2021//.
10. Werner L, Thatthamla I, Ong M, et al. Evaluation of clarity characteristics in a new hydrophobic acrylic IOL in comparison to commercially available IOLs. J Cataract Refract Surg. 2019;45(10):1490-1497.
11. Modi S, et al. Visual and patient-reported outcomes of a diffractive trifocal intraocular lens compared with those of a monofocal intraocular lens. Ophthalmology. 2021;128(2):197-207.
12. Zhu et al. Rate of Complete Spectacle Independence with a Trifocal IOL (PanOptix): A Systematic Literature Review and Meta-Analysis. Presentation at 2022 ASCRS; April 2022; Washington, D.C.
13. Market Scope 2022 IOL Market Report.
14. Alcon Data on File, 2022. [REF-18881].
15. Clareon^® PanOptix^® Trifocal IOL Directions for Use.
16. Clareon^® IOL Directions for use.
17. Oshika T, Fujita Y, Inamura M, Miyata K. Mid-term and long-term clinical assessments of a new 1-piece hydrophobic acrylic IOL with hydroxyethyl methacrylate. J Cataract Refract Surg. 2020;46(5):682-687.

Please refer to relevant products DFU or Operator’s manuals for complete list of indications, contraindications and warnings.
"Exclusive Use For Health Care Professionals".
"Product catalog may vary, check with your local distributor or representative".

Confidence:The Alcon Advantage

IOL Options for Every Patient